• Introduction

• Global Market Potential

• Key Drivers of Market

• Major Producers

• Technology Providers

• Leading Innovators 

• Production Processes

• Global Feedstock Options and Availability

• New technologies and Innovations

• End use Application

• Emerging and Future Opportunities

• Key Challenges

• Strategic Industry Initiatives

• Future Outlook

Introduction

Bio-based caprolactam is a renewable alternative to petroleum-derived caprolactam, the primary monomer used in the production of Nylon 6, one of the world’s most widely used engineering plastics and synthetic fibers. Unlike conventional caprolactam, which is produced from fossil-based feedstocks such as benzene and cyclohexane, bio-based caprolactam is manufactured using renewable biomass-derived intermediates through biotechnology, catalytic conversion, and green chemistry processes. It offers the potential to significantly reduce greenhouse gas emissions while maintaining compatibility with existing Nylon 6 manufacturing infrastructure.

Growing demand for sustainable engineering plastics, low-carbon materials, and circular manufacturing is accelerating research and commercialization of bio-based caprolactam. Emerging production pathways using bio-based adipic acid, lysine, muconic acid, 5-hydroxymethylfurfural (HMF), and lignocellulosic biomass are creating new opportunities for renewable Nylon 6 production. 

Global Market Potential

Parameter	Details
Current Market Size (2025)	USD 210-273 Million (bio-based caprolactam segment)
Projected Market Size (2030)	USD 280–400 Million
Projected Market Size (2035)	USD 380 – 514 Million
Expected CAGR (2025–2035)	6-8%
Annual Production Volume	50,000 tonnes
Major Producing Regions	Europe, North America, Japan, China
Major Consuming Regions	Asia-Pacific, Europe, North America
Primary Feedstocks	Glucose, Sugars, Lignocellulosic Biomass, Bio-based Adipic Acid, Bio-based Muconic Acid, Lysine, HMF Derivatives
Major End-Use Industries	Nylon 6 Fibers, Engineering Plastics, Automotive, Textiles, Electronics, Consumer Goods, Packaging

Current Market Size

The global bio-based caprolactam market has an estimated market value of USD 210-273  million in 2025. Demand is primarily driven by companies seeking low-carbon Nylon 6 for high-value applications.

Forecast (2030 & 2035)

The market is projected to reach USD 280–400(projected) million by 2030 and USD 380-514 million  2035, as bio-based production technologies mature and commercial-scale facilities are commissioned. Increasing sustainability commitments from the automotive, textile, electronics, consumer goods, and packaging industries are expected to accelerate adoption of renewable Nylon 6 value chains.

CAGR

The global bio-based caprolactam market is expected to grow at an impressive compound annual growth rate (CAGR) of approximately 6-8% between 2025 and 2035. This growth reflects the industry’s early stage of development, increasing investment in industrial biotechnology, and rising demand for sustainable engineering plastics.

Production Volume

Global production of bio-based caprolactam is currently estimated to be 50,000 tonnes annually. Europe, North America, Japan, and China are leading technology development through collaborations between biotechnology firms, chemical companies, and academic institutions. Significant capacity expansion is expected during the next decade as production processes become commercially competitive.

Demand Outlook

Demand for bio-based caprolactam is expected to increase rapidly due to several long-term market drivers:Growing demand for low-carbon Nylon 6 in automotive, electronics, textiles, and industrial manufacturing.Increasing corporate commitments to net-zero emissions and the replacement of fossil-based petrochemicals.Rising regulatory support for renewable chemicals, circular economy initiatives, and sustainable manufacturing.These trends position bio-based caprolactam as one of the most promising emerging platform chemicals for the future of sustainable polymers and engineering plastics, with strong long-term growth potential despite its current early stage of commercialization.

 

Key Drivers of  Caprolactum Market

Driver	Description
Growing Demand for Sustainable Nylon 6	Increasing demand for low-carbon Nylon 6 fibers and engineering plastics is driving interest in renewable caprolactam production.
Automotive Lightweighting & Electrification	Automotive manufacturers are adopting sustainable engineering plastics to reduce vehicle weight and carbon emissions, creating demand for bio-based caprolactam.
Corporate Net-Zero & ESG Commitments	Global chemical, textile, and consumer goods companies are replacing fossil-derived raw materials with renewable alternatives to meet sustainability goals.
Advancements in Industrial Biotechnology	Progress in metabolic engineering, precision fermentation, synthetic biology, and catalytic conversion is improving the commercial viability of bio-based caprolactam.
Expansion of Circular Bioeconomy	Increasing utilization of renewable biomass and waste-derived feedstocks supports circular manufacturing and reduces dependence on petroleum resources.
Government Support for Renewable Chemicals	Policies promoting decarbonization, green manufacturing, and bio-based materials are accelerating investment in renewable chemical production technologies.
Growing Demand for High-Performance Sustainable Materials	Industries such as electronics, textiles, aerospace, and consumer goods are seeking renewable materials without compromising mechanical performance.

 

Major Producers

Company / Organization	Country	Primary Focus
Toray Industries	Japan	R&D and commercialization of bio-based Nylon 6 and renewable caprolactam technologies for engineering plastics and fibers.
BASF SE	Germany	Development of sustainable polyamide value chains, including renewable feedstocks and low-carbon caprolactam production technologies.
Asahi Kasei Corporation	Japan	Research and development of low-carbon caprolactam and sustainable Nylon 6 production technologies.
UBE Corporation	Japan	One of the world’s leading caprolactam producers, investing in decarbonization and renewable production pathways for Nylon 6.

 

Technology Providers

Company	Country	Description
Genomatica (Geno)	United States	Precision fermentation platform for producing bio-based intermediates (e.g., bio-adipic acid and other C6 platform molecules) used as precursors for renewable caprolactam and Nylon 6 value chains.
Casale SA	Switzerland	Catalytic process engineering and reactor technologies for caprolactam synthesis, Beckmann rearrangement optimization, process intensification, and integrated caprolactam plant design, adaptable to renewable feedstocks.
thyssenkrupp Uhde	Germany	Integrated caprolactam production technology, including cyclohexanone oximation, Beckmann rearrangement, purification, and low-energy process integration for next-generation sustainable caprolactam plants.
Johnson Matthey	United Kingdom	Advanced heterogeneous catalysts for bio-based intermediate upgrading, hydrogenation, oxidation, and catalytic conversion required in renewable caprolactam production pathways.
Evonik Industries	Germany	Biocatalysis, amino acid fermentation (lysine platform), and specialty catalyst technologies supporting bio-based caprolactam production via lysine and other renewable intermediates.

 

Leading Innovators

Company / Organization	Country	Key Area of Innovation
Fraunhofer Institute	Germany	Catalytic conversion of biomass-derived intermediates (e.g., muconic acid and HMF derivatives) into renewable caprolactam and Nylon monomers.
National Renewable Energy Laboratory (NREL)	United States	Bioconversion of lignocellulosic biomass into bio-based platform chemicals and renewable intermediates for Nylon production.
Chinese Academy of Sciences (CAS)	China	Synthetic biology, metabolic engineering, and catalytic pathways for renewable caprolactam and bio-based polyamides.
DSM Engineering Materials (Envalior)	Netherlands	Development of sustainable engineering plastics using renewable monomers and circular polyamide technologies.
UBE Corporation	Japan	Process innovation for low-carbon caprolactam production, energy-efficient manufacturing, and sustainable Nylon 6 technologies.

 

Production Processes

Conventional Production

Conventional caprolactam is produced from petroleum-derived benzene through a multi-step chemical process involving the production of cyclohexane, oxidation to cyclohexanone/cyclohexanol (KA oil), conversion to cyclohexanone oxime, and finally the Beckmann rearrangement, which yields caprolactam. This mature process dominates global production but is energy-intensive and generates significant greenhouse gas emissions.

Bio-Based Production

Bio-based caprolactam is produced using renewable biomass-derived intermediates generated through precision fermentation, metabolic engineering, catalytic upgrading, and green chemistry. Emerging pathways utilize lysine, cis,cis-muconic acid, bio-based adipic acid, 5-hydroxymethylfurfural (HMF), glucose, and lignocellulosic biomass as renewable feedstocks. These intermediates are subsequently converted into caprolactam through catalytic and chemical transformation processes compatible with existing Nylon 6 manufacturing infrastructure.

Major Production Pathways

Production Pathway	Description	Commercial Status
Lysine-Based Fermentation Route	Fermentation of glucose to lysine followed by catalytic conversion into caprolactam.	Pilot to Demonstration
Muconic Acid Route	Fermentation-derived cis,cis-muconic acid is hydrogenated and cyclized to produce caprolactam precursors.	Pilot
Bio-Based Adipic Acid Route	Renewable adipic acid is chemically converted into caprolactam through catalytic processes.	Pilot
HMF/Furan-Based Route	Biomass-derived HMF or furan compounds are upgraded into caprolactam intermediates via catalytic chemistry.	Laboratory to Pilot
Lignocellulosic Biorefinery Route	Agricultural residues are converted into fermentable sugars and subsequently into renewable caprolactam intermediates.	Pilot

Key Production Microorganisms

Microorganism	Role in Production
Escherichia coli	Engineered for production of lysine, muconic acid, and other C6 platform chemicals.
Corynebacterium glutamicum	Industrial workhorse for high-yield lysine fermentation used in renewable caprolactam pathways.
Saccharomyces cerevisiae	Engineered for biomass sugar fermentation and production of aromatic intermediates.
Pseudomonas putida	Produces cis,cis-muconic acid and aromatic platform chemicals from renewable carbon sources.
Bacillus subtilis	Used for production of specialty enzymes and renewable biochemical intermediates.
Candida tropicalis	Investigated for bioconversion of renewable feedstocks into dicarboxylic acid intermediates.

Typical Production Flow

Bio-based caprolactam production begins with renewable biomass feedstocks such as sugars, lignocellulosic biomass, or biomass-derived platform chemicals. These feedstocks are converted through precision fermentation into intermediates such as lysine or cis,cis-muconic acid, or alternatively into bio-based adipic acid or HMF-derived compounds. The intermediates then undergo catalytic hydrogenation, cyclization, and chemical upgrading to form caprolactam. The final product is subsequently purified, crystallized, and refined to polymer-grade specifications before being supplied for the manufacture of Nylon 6 fibers, engineering plastics, films, and specialty materials.

Key Feedstocks & Intermediates

Feedstock / Intermediate	Role in Production
Glucose	Primary carbon source for microbial fermentation.
Lignocellulosic Biomass	Renewable feedstock converted into fermentable sugars for biochemical production.
Lysine	Major renewable intermediate used in emerging caprolactam production pathways.
cis,cis-Muconic Acid	Fermentation-derived platform chemical converted into caprolactam precursors.
Bio-based Adipic Acid	Renewable intermediate for catalytic synthesis of caprolactam.
5-Hydroxymethylfurfural (HMF)	Biomass-derived platform molecule investigated as a precursor for caprolactam synthesis.
Hydrogen	Used in catalytic hydrogenation and upgrading of renewable intermediates.
Catalysts (Metal-Based)	Facilitate hydrogenation, cyclization, and selective conversion into caprolactam.

 

 

Global Feedstock Options & Availability

Feedstock	Description	Global Availability & Key Regions	Advantages	Disadvantages
Glucose & Sugar Syrups	Fermentation feedstock derived from corn, sugarcane, and sugar beet.	United States, Brazil, India, China, Europe	Mature fermentation infrastructure, high purity, readily available.	Competes with food resources and subject to commodity price fluctuations.
Lignocellulosic Biomass	Agricultural residues such as corn stover, wheat straw, rice straw, bagasse, and forestry residues.	North America, Europe, China, India, Brazil	Abundant, low-cost, non-food feedstock, supports circular bioeconomy.	Requires costly pretreatment and hydrolysis technologies.
Bio-based Lysine	Fermentation-derived amino acid used as a renewable intermediate for caprolactam synthesis.	China, United States, Europe, South Korea	Commercially established fermentation process with high production volumes.	Requires additional catalytic conversion steps to produce caprolactam.
cis,cis-Muconic Acid	Renewable platform chemical produced through microbial fermentation of sugars.	Pilot production in North America, Europe, and China	Promising direct precursor for bio-based adipic acid and caprolactam pathways.	Limited commercial production and relatively high production costs.
Bio-based Adipic Acid	Renewable C6 dicarboxylic acid synthesized from biomass-derived intermediates.	Pilot-scale production in Europe, North America, and Asia	Existing downstream chemistry compatible with caprolactam production routes.	Commercial production capacity remains limited.
5-Hydroxymethylfurfural (HMF) & Furan Derivatives	Biomass-derived platform chemicals produced from sugars and cellulose.	Europe, United States, China, Japan	Versatile renewable intermediate for multiple specialty chemicals and polymers.	Early-stage commercialization and complex catalytic upgrading.
Industrial Sugar Streams & Molasses	Low-cost sugar-rich by-products from sugar processing industries.	Brazil, India, Thailand, China	Low-cost renewable feedstock, readily fermentable, supports waste valorization.	Variable composition and seasonal availability.
Forestry & Wood Residues	Cellulosic biomass obtained from forestry operations and wood-processing industries.	Canada, Scandinavia, United States, Russia	Large non-food biomass resource with long-term availability.	Requires advanced biomass conversion technologies and higher processing costs.

 

New Technologies & Innovations

Technology	Description	TRL	Advantages	Disadvantages	Example
Precision Fermentation for Lysine Production	Engineered microorganisms produce lysine, which is subsequently converted into bio-based caprolactam through catalytic processes.	TRL 7–8	High selectivity, scalable fermentation, renewable feedstocks.	Requires additional downstream catalytic conversion.	Evonik Industries, academic collaborations
Muconic Acid-Based Production Pathway	Microbial fermentation produces cis,cis-muconic acid, followed by catalytic hydrogenation and cyclization to caprolactam intermediates.	TRL 5–7	Avoids petroleum feedstocks and enables biomass-based production.	Still at pilot scale with relatively high production costs.	Genomatica (Geno), research institutions
Lignocellulosic Biorefinery Integration	Agricultural residues are converted into fermentable sugars and subsequently into renewable caprolactam intermediates within integrated biorefineries.	TRL 6–7	Utilizes non-food biomass, improves sustainability, supports circular bioeconomy.	Complex biomass pretreatment and lower overall process efficiency.	NREL, Fraunhofer Institute
Advanced Catalytic Conversion Technologies	High-performance catalysts improve hydrogenation, cyclization, and selective conversion of renewable intermediates into caprolactam.	TRL 7–8	Higher yields, improved selectivity, reduced energy consumption.	Catalyst cost and long-term stability remain challenges.	Johnson Matthey, BASF
Continuous Bioprocessing & Process Intensification	Continuous fermentation integrated with downstream purification improves production efficiency and reduces operating costs.	TRL 6–8	Increased productivity, lower capital costs, improved scalability.	Complex process control and industrial implementation.	Pilot-scale industrial biorefineries

 

End-use Applications

Application	Description	Benefits	Example
Nylon 6 Fibers	Primary monomer for manufacturing Nylon 6 fibers used in textiles, carpets, industrial yarns, and technical fabrics.	Lower carbon footprint while maintaining identical material performance.	Apparel, carpets, tire cords, industrial textiles
Engineering Plastics	Used to produce Nylon 6 engineering plastics for automotive, electrical, and industrial components.	High strength, durability, heat resistance, and sustainability.	Automotive parts, gears, bearings, connectors
Automotive Components	Renewable Nylon 6 used in lightweight structural and under-the-hood automotive applications.	Reduces vehicle weight and lifecycle carbon emissions.	EV battery housings, engine covers, air intake manifolds
Electrical & Electronics	Used in electrical insulation, connectors, cable ties, and electronic housings.	Excellent mechanical strength, thermal stability, and electrical insulation.	Connectors, switches, circuit components
Industrial Machinery	Manufacture of wear-resistant machine parts and industrial components using bio-based Nylon 6.	High abrasion resistance, long service life, and reduced carbon footprint.	Bushings, rollers, bearings, conveyor components

 

Emerging & Future Opportunities

Application Area	Future Opportunity	Description	Example / Current Development
Sustainable Nylon 6	Low-Carbon Engineering Plastics	Large-scale replacement of fossil-derived caprolactam with renewable alternatives for Nylon 6 production.	Bio-based Nylon 6 for automotive and industrial applications
Electric Vehicles (EVs)	Lightweight Mobility Solutions	Increasing use of renewable Nylon 6 in battery systems, electrical components, and lightweight vehicle parts.	EV battery housings, cable connectors, charging infrastructure
Textiles & Technical Fibers	Sustainable Performance Fibers	Development of renewable Nylon 6 fibers for apparel, carpets, industrial yarns, and technical textiles.	Eco-friendly sportswear, industrial fabrics, tire cords
Circular Polyamide Economy	Renewable & Recyclable Nylon Value Chains	Integration of bio-based caprolactam with mechanical and chemical recycling to create circular Nylon 6 production systems.	Closed-loop Nylon recycling and renewable polymer manufacturing
Advanced Manufacturing	Bio-based 3D Printing Materials	Production of renewable Nylon 6 filaments and powders for additive manufacturing and industrial prototyping.	Aerospace and industrial 3D printing applications
High-Performance Electronics	Sustainable Engineering Components	Increased use of renewable polyamides in electrical insulation, connectors, and electronic housings.	Consumer electronics and electrical equipment
Integrated Biorefineries	Biomass-to-Polymer Platforms	Production of caprolactam alongside other renewable chemicals from agricultural residues and lignocellulosic biomass.	Multi-product lignocellulosic biorefineries

 

Key Challenges

1. High Production Costs

Bio-based caprolactam remains significantly more expensive than conventional petroleum-derived caprolactam due to the costs associated with precision fermentation, biomass processing, catalyst systems, and downstream purification. Achieving cost parity remains one of the industry’s biggest commercialization challenges.

Example: Pilot-scale bio-based caprolactam production is currently unable to compete economically with large-scale petrochemical plants benefiting from decades of process optimization.

2. Limited Commercial-Scale Production

Most bio-based caprolactam technologies remain at the pilot or demonstration stage, with only limited commercial production capacity worldwide. Scaling these technologies while maintaining product quality and process efficiency remains a major hurdle.

Example: Most renewable production pathways involving lysine, muconic acid, and bio-based adipic acid have not yet reached full industrial-scale deployment.

3. Complex Multi-Step Conversion Pathways

Unlike conventional caprolactam production, many renewable pathways require multiple biological and catalytic conversion steps, increasing process complexity, capital investment, and operational costs.

Example: The lysine pathway requires microbial fermentation followed by several catalytic upgrading steps before polymer-grade caprolactam can be obtained.

4. Feedstock Availability & Supply Chain Challenges

Although renewable feedstocks are abundant, maintaining a consistent, high-quality, and economically viable supply of sugars, lignocellulosic biomass, and bio-based intermediates remains challenging. Seasonal variability and logistics can also affect production economics.

Example: Agricultural residues and biomass feedstocks require extensive collection, storage, and pretreatment before fermentation.

5. Competition from Established Petrochemical Production

Conventional caprolactam production is supported by highly optimized, large-scale manufacturing infrastructure, making it difficult for emerging bio-based technologies to compete on cost and production volume.

Example: Major petrochemical producers such as BASF, UBE Corporation, and DOMO Chemicals operate highly efficient global caprolactam facilities with established supply chains.

6. Technology Maturity & Investment Risk

Many production pathways for bio-based caprolactam rely on emerging fermentation technologies, advanced catalysts, and synthetic biology, which still require further technical validation and significant capital investment before widespread commercialization.

Example: Production routes based on cis,cis-muconic acid, HMF, and lignocellulosic biomass continue to undergo optimization to improve yields, scalability, and long-term economic viability.

 

Strategic Industry Initiatives

Industrial Biotechnology & Chemical Companies

Commercialization of Renewable Caprolactam Technologies

Chemical manufacturers and biotechnology companies are investing in bio-based caprolactam production technologies to reduce dependence on fossil feedstocks while supplying low-carbon monomers for the Nylon 6 industry. Strategic collaborations are focused on scaling renewable production pathways and integrating them into existing polyamide manufacturing infrastructure.

Example: Genomatica (Geno) is developing precision fermentation technologies for renewable C6 platform chemicals that can serve as precursors for bio-based caprolactam and sustainable Nylon value chains.

Location: United States

Development of Sustainable Nylon 6 Value Chains

Major nylon manufacturers are integrating renewable feedstocks, recycled polyamides, and low-carbon manufacturing processes to produce more sustainable Nylon 6 products without compromising performance.

Example: Toray Industries is investing in sustainable polyamide technologies and renewable raw materials to reduce the environmental footprint of high-performance Nylon products.

Location: Japan

Technology & Process Innovation

Precision Fermentation & Synthetic Biology

Technology developers are engineering high-performance microbial strains capable of producing renewable intermediates such as lysine, cis,cis-muconic acid, and bio-based adipic acid, improving production efficiency and reducing reliance on petrochemicals.

Example: The National Renewable Energy Laboratory (NREL) is developing biomass conversion and precision fermentation technologies for renewable platform chemicals used in polymer production.

Location: United States

Advanced Catalytic Conversion Technologies

Research organizations and catalyst developers are improving hydrogenation, cyclization, Beckmann rearrangement, and purification technologies to enhance the efficiency and economics of renewable caprolactam production.

Example: Johnson Matthey is developing advanced catalyst technologies for biomass upgrading and sustainable chemical manufacturing.

Location: United Kingdom

Sustainable Materials & Circular Economy

Circular Nylon Manufacturing

Manufacturers are combining bio-based caprolactam with mechanical and chemical recycling technologies to establish circular Nylon 6 value chains that reduce fossil resource consumption and polymer waste.

Example: DOMO Chemicals is integrating renewable feedstocks, recycled polyamides, and circular manufacturing strategies for sustainable engineering plastics.

Location: Belgium

Integrated Biorefineries

Industrial biotechnology companies are developing integrated biorefineries capable of producing bio-based caprolactam alongside other renewable chemicals and fuels from agricultural residues and lignocellulosic biomass, improving overall process economics.

Example: Fraunhofer Institute is conducting research on integrated biomass conversion technologies for renewable chemical production.

Location: Germany

Governments & Research Organizations

Investment in Renewable Polymer Technologies

Governments and research agencies are supporting projects focused on bio-based polymers, industrial biotechnology, synthetic biology, and low-carbon chemical manufacturing to accelerate commercialization of renewable caprolactam.

Example: The U.S. Department of Energy (DOE) funds research on sustainable polymer feedstocks, advanced biomanufacturing, and biomass conversion technologies through national laboratories and industrial partnerships.

Location: United States

Support for Circular Economy & Low-Carbon Manufacturing

Governments worldwide are implementing policies that promote renewable chemicals, circular manufacturing, industrial decarbonization, and sustainable materials, encouraging investment in bio-based Nylon 6 value chains.

Example: The European Union Circular Economy Action Plan supports the development of renewable polymers, advanced recycling technologies, and sustainable chemical manufacturing.

Location: European Union

 

Future Outlook

Technology Roadmap

The future of bio-based caprolactam will be driven by advances in precision fermentation, synthetic biology, metabolic engineering, advanced catalytic conversion and  and integrated biorefineries. These technologies are expected to improve fermentation yields, reduce production costs, diversify renewable feedstocks, and enable commercial-scale production of low-carbon caprolactam compatible with existing Nylon 6 manufacturing infrastructure.

Five-Year Outlook (2025–2030)

Over the next five years, the bio-based caprolactam industry is expected to transition from pilot and demonstration projects toward early commercial production. Investments will focus on scaling lysine- and muconic acid-based production pathways, improving catalyst efficiency, and integrating renewable intermediates into existing Nylon 6 value chains. Increasing sustainability commitments from the automotive, textile, electronics, and consumer goods industries will further accelerate market adoption.

Ten-Year Outlook (2030–2035)

By 2035, bio-based caprolactam is expected to become a commercially viable renewable monomer for Nylon 6, supported by large-scale deployment of precision fermentation, lignocellulosic biorefineries, and advanced catalytic technologies. Broader adoption of renewable engineering plastics across electric vehicles, industrial manufacturing, textiles, packaging, and electronics is expected to significantly expand market demand. Improved process economics and supportive decarbonization policies will further strengthen global commercialization.

Conclusion

Bio-based caprolactam represents one of the most promising emerging renewable platform chemicals for the global polymer industry, providing a sustainable alternative to fossil-derived caprolactam used in the production of Nylon 6. By utilizing renewable biomass, precision fermentation, and advanced catalytic conversion technologies, it has the potential to significantly reduce greenhouse gas emissions while maintaining full compatibility with existing Nylon 6 manufacturing infrastructure. This makes bio-based caprolactam an attractive solution for industries seeking high-performance materials with a lower environmental footprint.

Despite challenges such as high production costs, limited commercial-scale capacity, complex conversion pathways, and competition from mature petrochemical production, rapid advancements in synthetic biology, metabolic engineering, catalyst development,  and integrated biorefineries  are steadily improving its commercial viability. Growing investments from biotechnology companies, chemical manufacturers, and polymer producers are expected to accelerate technology commercialization and reduce production costs over the coming decade.

 

Explore Other Bio-based Chemicals

Category	Chemicals
Organic Acids	Citric Acid  Lactic Acid  Succinic Acid  Fumaric Acid  Malic Acid  Gluconic Acid  Itaconic Acid  Levulinic Acid  Adipic Acid  Muconic Acid
Platform Chemicals & Intermediates	Furfural  Bio-based Acrylic Acid  Caprolactam
Alcohols & Biofuels	Biomethanol  Biobutanol  Glycerol
Biopolymers & Bioplastics	PLA (Polylactic Acid)  PHA (Polyhydroxyalkanoates)  PBS (Polybutylene Succinate)
Biopolymers & Biopolysaccharides	Xanthan Gum  Alginate  Chitosan
Sugar-derived Chemicals & Polyols	Xylitol  Sorbitol
Specialty Chemicals & Functional Ingredients	Biosurfactants  Sebacic Acid  12-Hydroxystearic Acid (12-HSA)  Glutamic Acid
Bio-based Hydrocarbons & Monomers	Bio-Isoprene  Farnesene